Refined design preview / not a live website / registrations not active
PSYCH
CPDEVENTS FOR THERAPISTS
The people / 06 perspectives

The people
behind the programme.

Meet the practitioners and researchers contributing clinical experience, scholarship and different perspectives to Psychedelic CPD Events.

Portrait displayed for Greg Donaldson on the existing Psychedelic CPD Events website
01 / 06

Greg Donaldson

Founder / Psychotherapist / Psychedelic Guide / Facilitator

Greg Donaldson is a UKCP psychosynthesis psychotherapist and clinical supervisor who works in Brighton and online. He is especially interested in the way people make meaning of their experiences, including the use of archetypal perspectives in therapy. His approach invites greater acceptance of ourselves, our relationships and the different parts of our inner lives.

Greg studied at the Psychosynthesis Trust, gaining an MA in Psychosynthesis Psychotherapy, and subsequently taught applied psychosynthesis there between 2021 and 2024. Alongside his private practice, he has developed a particular interest in how people prepare for and integrate significant or transformative experiences.

He worked as a psychedelic guide on Imperial College London's phase-two research involving people with treatment-resistant depression. He later helped facilitate a London psychedelic integration group and was involved in founding the Brighton psychedelic integration group. During 2019–20 he also supported an online Synthesis Institute integration programme shaped by Rosalind Watts's nature-based approach.

In 2023 Greg led work on an integration protocol for an ibogaine clinical trial at Hammersmith Medicines Research. His private practice continues to include support for people seeking to prepare for, understand and integrate psychedelic experiences within a grounded therapeutic relationship.

Compare with Greg's original Squarespace biography ↗

Greg's professional website ↗
Portrait displayed for Michelle Baker Jones on the existing Psychedelic CPD Events website
02 / 06

Michelle Baker Jones

Therapist / Psychedelic Guide / Speaker / Facilitator

Michelle Baker Jones is an integrative psychotherapeutic counsellor with a private practice in London. Her clinical work is informed by several therapeutic perspectives and by sustained involvement in psychedelic research. She has been associated with Imperial College London's Psychedelic Research Group since 2015.

On Imperial's Psilodep 2 study, Michelle served as a lead guide in research comparing psilocybin with escitalopram for depression. She subsequently worked as a lead therapist on Small Pharma's studies of DMT-assisted psychotherapy, contributing to the therapeutic framework and training used in that research.

Her work in professional education includes co-designing the Beckley Academy's Foundations to Psychedelic-Assisted Therapy course and helping develop therapist preparation for DMT trials. She brings together research experience, relational counselling and an interest in careful, ethical training for practitioners.

Michelle also supports individuals trying to make sense of challenging or significant psychedelic experiences. She co-facilitates a specialist integration group associated with the Institute of Psychedelic Therapy and has contributed to broader harm-reduction and psychoeducation initiatives.

Compare with Greg's original Squarespace biography ↗

Michelle's professional website ↗ · King's College London profile ↗
Portrait displayed for Hattie Wells on the existing Psychedelic CPD Events website
03 / 06

Hattie Wells

Psychedelic Guide / Speaker / Facilitator

Hattie Wells is a psychedelic practitioner, ethnobotanist and advocate for reform of drug policy. She is a director of Breaking Convention and has spent more than two decades working to improve understanding of psychedelics, their potential applications and the risks that need to be addressed.

Her early work included helping facilitate ibogaine treatment experiences in the UK in the 2000s, with particular attention to the interruption of addictive patterns. She has continued to follow research on ibogaine as well as other compounds, combining practical knowledge with an emphasis on the circumstances in which people seek these experiences.

Hattie has worked with organisations including the Beckley Foundation, Transform Drug Policy Foundation and ICEERS. Across this work she has advocated for more informed drug education, harm reduction and approaches to policy that acknowledge both potential benefits and possible harms.

She has also worked as a guide or research therapist in clinical investigations involving psychedelic substances, including ibogaine, LSD and 5-MeO-DMT. Her contribution to the programme brings together clinical research experience, ethnobotany, public education and a long-standing commitment to safer practice.

Compare with Greg's original Squarespace biography ↗

Breaking Convention profile ↗
Portrait displayed for Dr Graham Campbell on the existing Psychedelic CPD Events website
04 / 06

Dr Graham Campbell

Psychiatrist / Speaker / Facilitator

Dr Graham Campbell is a psychiatrist based in Brighton with extensive NHS and psychedelic-research experience. He spent 15 years working in NHS mental health services, including eight years as a consultant psychiatrist in Brighton and Hove, and holds a master's degree in neuroscience from King's College London.

Graham trained with Imperial College London's psychedelic research group and served as an assistant guide on the Psilodep 2 trial comparing psilocybin with escitalopram for depression. Since 2019, he has also helped establish and facilitate psychedelic integration groups in Brighton, supporting thoughtful discussion of experiences outside the research setting.

In 2020 he moved from NHS employment into research involving DMT-assisted psychotherapy, working as a trial psychiatrist and guide with Small Pharma. His contribution also included the development of therapeutic frameworks and training for clinicians supporting participants in DMT studies. He has worked with the Institute of Psychedelic Therapy, including its advisory and academic discussion activities.

Beyond clinical trials, Graham has contributed to academic writing on the potential medical uses of psychedelics, worked with the MIND Foundation's training programmes and advised Lumenate. He also has a private psychiatry practice in Brighton.

Compare with Greg's original Squarespace biography ↗

MIND Foundation profile ↗
Portrait displayed for Dr Rosalind Watts on the existing Psychedelic CPD Events website
05 / 06

Dr Rosalind Watts

Clinical Psychologist / Speaker / Facilitator

Dr Rosalind Watts is a clinical psychologist whose research and clinical work have helped shape contemporary conversations about psychedelic therapy. She was Clinical Lead for Imperial College London's psilocybin research with people experiencing depression, and has spoken widely about what participants may need after an intense therapeutic experience.

Rosalind's central focus is integration: how insights, difficulties and changes experienced in altered states can be supported over time. Her work explores the importance of connection with oneself, other people and the natural world, alongside inclusion, safety and harm reduction.

She was involved in the early development of psychedelic integration groups in the UK and founded ACER Integration in 2022. ACER stands for Accept, Connect, Embody and Restore and offers a long-term, nature-informed online programme in which participants work alongside a community over 13 months.

Rosalind has also developed the Watts Connectedness Scale, a research measure concerned with people's sense of connection. Across her work, she argues for giving sustained attention to the relationships, settings and ongoing support that can help make integration meaningful.

Compare with Greg's original Squarespace biography ↗

Rosalind's website ↗ · ACER Integration ↗
Portrait displayed for Tom Shutte on the existing Psychedelic CPD Events website
06 / 06

Tom Shutte

Psychotherapist / Speaker / Facilitator

Tom Shutte is a psychotherapist and clinical supervisor whose work crosses private practice, therapeutic training and research into psychedelic-assisted treatment. His interest in psychosynthesis began early, influenced by Roberto Assagioli's writing on spiritual emergency and the ways people respond to powerful inner experiences.

During his psychotherapy training he investigated the use of psychosynthesis to help people integrate experiences involving ayahuasca, bringing together a transpersonal understanding of therapy with questions about emotional and psychological support.

Tom contributed to the Manual of Psychedelic Support and worked at Wavepaths, where he became Clinical Lead. His work there explored how carefully developed music experiences can support therapeutic settings and the preparation and training of practitioners.

He has subsequently worked as a lead therapist or guide in UK research involving compounds such as ibogaine, 5-MeO-DMT, methylone and psilocybin. Alongside this clinical research, he works in psychotherapy, supervision and practitioner education, with particular attention to trauma-informed, relational and somatic approaches to integration.

Compare with Greg's original Squarespace biography ↗

Tom's practice ↗ · Institute of Psychedelic Therapy profile ↗
These are full-length editorial biographies prepared for review against Greg's original Squarespace page and the contributors' professional profiles. Greg should approve current roles, affiliations, photographs and links before the replacement website goes live.
Back to the conversation

Interested in
future training?

Watch this space for future CPD events. The new signup form isn't connected yet. For event or professional enquiries, email psychedeliccpd@gmail.com. Enquiries are not marketing subscriptions.

Back to the homepage